LobbyingCenter for American Medicine Resiliency lobbying by quarter
Center for American Medicine Resiliency's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2024; the issues it reports most are Health Issues and Homeland Security.
Center for American Medicine Resiliency
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 2 reports
- Homeland security$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Defense, Dept of (DOD)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- Natl Security Council (NSC)2 reports
- SENATE2 reports
- White House Office2 reports
- Bureau of Industry and Security (BIS)1 reports
- Commerce, Dept of (DOC)1 reports
- Federal Trade Commission (FTC)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCenter for American Medicine Resiliency | $0 | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/13for Q2 | In-house | Under $5,000 |
| 02/14for Q4 2025 | In-house | Under $5,000 |
| 25/02/23for Q4 2024 | In-house | Under $5,000 |
| 24/08/12for Q2 2024 | In-house | Under $5,000 |
| 24/05/20for Q1 2024 | In-house | Under $5,000 |